232 related articles for article (PubMed ID: 30400936)
21. Research on the potential mechanism of Chuanxiong Rhizoma on treating Diabetic Nephropathy based on network pharmacology.
Hu S; Chen S; Li Z; Wang Y; Wang Y
Int J Med Sci; 2020; 17(15):2240-2247. PubMed ID: 32922187
[No Abstract] [Full Text] [Related]
22. A network pharmacology approach to determine the underlying mechanisms of action of Yishen Tongluo formula for the treatment of oligoasthenozoospermia.
Chen Y; Bi F; Sun Z
PLoS One; 2021; 16(6):e0252906. PubMed ID: 34153045
[TBL] [Abstract][Full Text] [Related]
23. Exploring the Pharmacological Mechanisms of
Huang B; Huang C; Zhu L; Xie L; Wang Y; Zhu N
Biomed Res Int; 2021; 2021():5575621. PubMed ID: 34435046
[TBL] [Abstract][Full Text] [Related]
24. Research on the Mechanism of Guizhi to Treat Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking Technology.
He D; Li Q; Du G; Sun J; Meng G; Chen S
Biomed Res Int; 2021; 2021():8141075. PubMed ID: 34873575
[TBL] [Abstract][Full Text] [Related]
25. Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties.
Si J; Ma Y; Bi JW; Xiong Y; Lv C; Li S; Wu N; Yang Y
J Exp Clin Cancer Res; 2019 Dec; 38(1):481. PubMed ID: 31801598
[TBL] [Abstract][Full Text] [Related]
26. Identification of the Active Compounds and Significant Pathways of Artemisia Annua in the Treatment of Non-Small Cell Lung Carcinoma based on Network Pharmacology.
Zhang SQ; Xu HB; Zhang SJ; Li XY
Med Sci Monit; 2020 May; 26():e923624. PubMed ID: 32474568
[TBL] [Abstract][Full Text] [Related]
27. Exploring the mechanism and experimental validation of Fuzi Lizhong Tang in treating gastric cancer based on network pharmacology and molecular docking.
Zhang FY; Guo SC
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9192-9204. PubMed ID: 37843333
[TBL] [Abstract][Full Text] [Related]
28. Study on the potential active components and molecular mechanism of Xiao Huoluo Pills in the treatment of cartilage degeneration of knee osteoarthritis based on bioinformatics analysis and molecular docking technology.
Chen W; Lin T; He Q; Yang P; Zhang G; Huang F; Wang Z; Peng H; Li B; Liang D; Wang H
J Orthop Surg Res; 2021 Jul; 16(1):460. PubMed ID: 34273999
[TBL] [Abstract][Full Text] [Related]
29. A network pharmacology approach to explore active compounds and pharmacological mechanisms of a patented Chinese herbal medicine in the treatment of endometriosis.
Wu Y; Zhu Y; Xie N; Wang H; Wang F; Zhou J; Qu F
PLoS One; 2022; 17(2):e0263614. PubMed ID: 35130311
[TBL] [Abstract][Full Text] [Related]
30. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation.
Zhang Z; Liu J; Liu Y; Shi D; He Y; Zhao P
J Ethnopharmacol; 2021 Apr; 269():113696. PubMed ID: 33358854
[TBL] [Abstract][Full Text] [Related]
31. Exploring the mechanism of aidi injection for lung cancer by network pharmacology approach and molecular docking validation.
Zhuang Z; Lin T; Luo L; Zhou W; Wen J; Huang H; Liu Z; Lin L
Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33506873
[TBL] [Abstract][Full Text] [Related]
32. [Molecular mechanism of Spatholobi Caulis in treatment of lung cancer based on network pharmacology and molecular docking].
Chen K; Jin C; Cheng YY; Zhang QX; Li XX; Zhang L
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):837-844. PubMed ID: 33645088
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
[TBL] [Abstract][Full Text] [Related]
34. Mechanism exploration and prognosis study of Astragali Radix-Spreading hedyotis herb for the treatment of lung adenocarcinoma based on bioinformatics approaches and molecular dynamics simulation.
Guo J; Zhao Y; Wu X; Li G; Zhang Y; Song Y; Du Q
Front Chem; 2023; 11():1128671. PubMed ID: 37065830
[No Abstract] [Full Text] [Related]
35. Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure.
Yamaoka T; Ohba M; Arata S; Ohmori T
J Vis Exp; 2017 Aug; (126):. PubMed ID: 28829429
[TBL] [Abstract][Full Text] [Related]
36. Network pharmacology-based screening of the active ingredients and mechanisms of evodiae fructus anti-glioblastoma multiforme.
Wu G; Hao Q; Liu B; Zhou J; Fan C; Liu R
Medicine (Baltimore); 2022 Sep; 101(39):e30853. PubMed ID: 36181021
[TBL] [Abstract][Full Text] [Related]
37. Acquired Resistance Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in Met-Amplified EGFR-TKI-Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation.
Yamaoka T; Ohmori T; Ohba M; Arata S; Kishino Y; Murata Y; Kusumoto S; Ishida H; Shirai T; Hirose T; Ohnishi T; Sasaki Y
Mol Cancer Ther; 2016 Dec; 15(12):3040-3054. PubMed ID: 27612490
[TBL] [Abstract][Full Text] [Related]
38. [Mechanism of Astragali Radix-Curcumae Rhizoma in treating gastric cancer based on network pharmacology and experimental verification].
Tan XY; Tao J; Zhang Y; Gu RX
Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):5056-5067. PubMed ID: 37802848
[TBL] [Abstract][Full Text] [Related]
39. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
40. Targeting YAP-p62 signaling axis suppresses the EGFR-TKI-resistant lung adenocarcinoma.
Park HS; Lee DH; Kang DH; Yeo MK; Bae G; Lee D; Yoo G; Kim JO; Moon E; Huh YH; Lee SH; Jo EK; Cho SY; Lee JE; Chung C
Cancer Med; 2021 Feb; 10(4):1405-1417. PubMed ID: 33486901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
